Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine, Norepinephrine and Epinephrine in Pulmonary Hypertensive Crisis
NCT07667829Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised trial in pulmonary hypertension (PH) comparing Norepinephrine group, Dopamine group and Epinephrine group (3 arms). Primary endpoint: All-cause mortality within 28 days. Started Aug 2026; status: recruiting.
02
Drugs
norepinephrinedopamineepinephrine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07667829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07667829.